Curaleaf Holdings, Inc. (CURA.TO) AI-Powered Stock Analysis
See how Curaleaf Holdings, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
CURA.TO●TSX
HealthcareDrug Manufacturers - Specialty & Generic
$14.06
$0.16(1.13%)
Canadian Market is Open · 09:40
Advertisement
Curaleaf Holdings, Inc. (CURA.TO)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerCuraleaf Holdings, Inc. (CURA.TO) Stock Overall Grade
Curaleaf Holdings, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Curaleaf Holdings, Inc.'s overall stock rating.
Forecast
C+Score
54/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
51/100Key Ratios
C+Score
53/100Sector Comparison
C+Score
50/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Curaleaf Holdings, Inc. (CURA.TO) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 54/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (51/100, C+) highlight its stability, while Key Ratios (53/100, C+) and Sector Comparison (50/100, C+) indicate weak positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests Low divergence in outlook.Component Analysis Explained
Understand the key factors behind each Curaleaf Holdings, Inc. stock grade, including financials, comparisons, and forecasts.